Certara is the global leader in advancing modern, efficient drug development.

We provide proven modeling & simulation, regulatory and real-world value assessment software and services. In partnership with our clients, we help reduce clinical trial burden, accelerate regulatory approval and increase patient access to medicines.

Certara Supported 90+ Percent of US FDA Novel New Drug Approvals
for Fourth Consecutive Year

Certara is the global leader in advancing modern, efficient drug development.

We provide proven modeling & simulation, regulatory and real-world value assessment software and services. In partnership with our clients, we help reduce clinical trial burden, accelerate regulatory approval and increase patient access to medicines.

Certara’s Simcyp® Model and Simulation Technology Achieves First FDA Virtual Bioequivalence Approval for ‘Complex’ Generic Drug

Certara is the global leader in advancing modern, efficient drug development.

We provide proven modeling & simulation, regulatory and real-world value assessment software and services. In partnership with our clients, we help reduce clinical trial burden, accelerate regulatory approval and increase patient access to medicines.

CDC Selects Certara to Develop Innovative Technology Platform

Certara is the global leader in advancing modern, efficient drug development.

We provide proven modeling & simulation, regulatory and real-world value assessment software and services. In partnership with our clients, we help reduce clinical trial burden, accelerate regulatory approval and increase patient access to medicines.

Introducing Certara’s Integral. A Next Generation FDA-Compliant Data Repository that Streamlines Clinical Pharmacology Workflow

Learn More With Certara

Focused on accelerating the pace of innovation in our field, Certara’s scientists and regulatory experts share learnings, technological advances, and thought leadership.

Leveraging Public Data for Strategic Drug Development More Common Myths about PBPK for Drug Development Busted! More A Guide to Successful Market Access More Best Practices for Developing Investigational Drug Submissions More

最新情報

Blog

In the Press

Webinars